APA (7th ed.) Citation

GS, C., S, P., L, M., C, J., R, G., S, V., . . . AS, W. (2021). Strategic treatment optimization for HCV (STOPHCV1): A randomised controlled trial of ultrashort duration therapy for chronic hepatitis C. Wellcome open research, 6, 93. https://doi.org/10.12688/wellcomeopenres.16594.2

Chicago Style (17th ed.) Citation

GS, Cooke, et al. "Strategic Treatment Optimization for HCV (STOPHCV1): A Randomised Controlled Trial of Ultrashort Duration Therapy for Chronic Hepatitis C." Wellcome Open Research 6 (2021): 93. https://doi.org/10.12688/wellcomeopenres.16594.2.

MLA (9th ed.) Citation

GS, Cooke, et al. "Strategic Treatment Optimization for HCV (STOPHCV1): A Randomised Controlled Trial of Ultrashort Duration Therapy for Chronic Hepatitis C." Wellcome Open Research, vol. 6, 2021, p. 93, https://doi.org/10.12688/wellcomeopenres.16594.2.